NOS cofactor tetrahydrobiopterin contributes to anesthetic preconditioning induced myocardial protection in the isolated ex vivo rat heart

Wang,Chen; Qiao,Shigang; Hong,Lei; Sun,Jie; Che,Tuanjie; An,Jianzhong; Camara,Amadou  K.S.

doi:10.3892/ijmm.2019.4445

NOS cofactor tetrahydrobiopterin contributes to anesthetic preconditioning induced myocardial protection in the isolated ex vivo rat heart

Authors:
- Chen Wang
- Shigang Qiao
- Lei Hong
- Jie Sun
- Tuanjie Che
- Jianzhong An
- Amadou K.S. Camara
View Affiliations

Affiliations: Institute of Clinical Medicine Research, Suzhou, Jiangsu 215153, P.R. China, Laboratory of Precision Medicine and Translational Medicine, The Affiliated Suzhou Science and Technology Town Hospital of Nanjing Medical University, Suzhou, Jiangsu 215153, P.R. China, Department of Anesthesiology and Physiology,  Medical College of Wisconsin, Milwaukee, WI 53226, USA
Published online on: December 27, 2019 https://doi.org/10.3892/ijmm.2019.4445
Pages: 615-622

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Anesthetic preconditioning (APC) may decrease the myocardium injury nearly 50% following ischemia/reperfusion (I/R) by enhancing recovery of cardiac function, reducing myocardial enzyme release and lowering infarct size when utilized as pretreatment or posttreatment agents. I/R increases nitric oxide (NO) production through endothelial NO synthase (NOS3) and heat shock protein 90 (HSP90). The present study aimed to observe the role of BH4 availability and the association of HSP90 with NOS3 in APC‑mediated cardioprotection against I/R injury. Isolated rat hearts were subjected to no‑flow ischemia for 30 min and reperfusion for 120 min. Sevoflurane (3.5%) was administered for 15 min followed by a 15 min washout prior to ischemia. 2,4-Diamino-6-hydroxypyrimidine (DAHP) or sepiapterin (SP) was administered for 40 min until the onset of ischemia. The results revealed that compared with pre‑ischemic basal levels, BH4 levels decreased and BH2 levels increased following I/R. BH4 levels were significantly increased and BH2 levels were significantly decreased in the APC + I/R hearts compared with the I/R group hearts. The BH4:BH2 ratio in the APC‑treated hearts was also increased compared with that in the I/R group hearts. SP increased the recovery of contractile function and the production of NO, and decreased the production of superoxide anion (O2·‑) in I/R heart, but did not elicit these effects in APC‑treated hearts. DAHP treatment inhibited the APC‑mediated recovery of contractile function, increased O2·‑ levels and decreased NO production, but had no effect in I/R hearts. The cardioprotection of APC was demonstrated to be modulated by the BH4 precursor SP, which increased BH4 levels, or DAHP, which inhibited GTP cyclohydrolase I. Both APC and SP treatments increased the combination of HSP90 and NOS3, which improved the NOS3 activity and function. The results suggested that BH4, which servesas a cofactor for NOS, mediated the resistance of APC to I/R injury by promoting the binding of HSP90 and NOS3.

View Figures

View References

1	Bredt DS and Snyder SH: Nitric oxide: A physiologic messenger molecule. Annu Rev Biochem. 63:175–195. 1994. View Article : Google Scholar : PubMed/NCBI
2	Ziolo MT, Kohr MJ and Wang H: Nitric oxide signaling and the regulation of myocardial function. J Mol Cell Cardiol. 45:625–632. 2008. View Article : Google Scholar : PubMed/NCBI
3	Gaynullina DK, Schubert R and Tarasova OS: Changes in endothelial nitric oxide production in systemic vessels during early ontogenesis-A key mechanism for the perinatal adaptation of the circulatory system. Int J Mol Sci. 20:pii: E1421. 2019. View Article : Google Scholar : PubMed/NCBI
4	Yuyun MF, Ng LL and Ng GA: Endothelial dysfunction, endothelial nitric oxide bioavailability, tetrahydrobiopterin, and 5-methyltetrahydrofolate in cardiovascular disease. Where are we with therapy? Microvasc Res. 119:7–12. 2018.
5	Xie L, Hu D, Qin H, Zhang W, Zhang S, Feng Y, Yao H, Xiao Y, Yao K and Huang X: In vivo gum arabic-coated tetrahydrobi-opterin protects against myocardial ischemia reperfusion injury by preserving eNOS coupling. Life Sci. 219:294–302. 2019. View Article : Google Scholar : PubMed/NCBI
6	Dumitrescu C, Biondi R, Xia Y, Cardounel AJ, Druhan LJ, Ambrosio G and Zweier JL: Myocardial ischemia results in tetrahydrobiopterin (BH4) oxidation with impaired endothelial function ameliorated by BH4. Proc Natl Acad Sci USA. 104:15081–15086. 2007. View Article : Google Scholar : PubMed/NCBI
7	Shi Y, Hutchins W, Ogawa H, Chang CC, Pritchard KA Jr, Zhang C, Khampang P, Lazar J, Jacob HJ, Rafiee P and Baker JE: Increased resistance to myocardial ischemia in the Brown Norway vs Dahl S rat: Role of nitric oxide synthase and Hsp90. J Mol Cell Cardiol. 38:625–635. 2005. View Article : Google Scholar : PubMed/NCBI
8	An J, Du J, Wei N, Xu H, Pritchard KA Jr and Shi Y: Role of tetrahydrobiopterin in resistance to myocardial ischemia in Brown Norway and Dahl S rats. Am J Physiol Heart Circ Physiol. 297:H1783–H1791. 2009. View Article : Google Scholar : PubMed/NCBI
9	Xie L, Talukder MA, Sun J, Varadharaj S and Zweier JL: Liposomal tetrahydrobiopterin preserves eNOS coupling in the post-ischemic heart conferring in vivo cardioprotection. J Mol Cell Cardiol. 86:14–22. 2015. View Article : Google Scholar : PubMed/NCBI
10	Kawahara K, Takase M and Yamauchi Y: Increased vulnerability to ischemia/reperfusion-induced ventricular tachyarrhythmias by pre-ischemic inhibition of nitric oxide synthase in isolated rat hearts. Cardiovasc Pathol. 12:49–56. 2003. View Article : Google Scholar : PubMed/NCBI
11	Baotic I, Weihrauch D, Procknow J, Vasquez-Vivar J, Ge ZD, Sudhakaran S, Warltier DC and Kersten JR: Isoflurane favorably modulates guanosine triphosphate cyclohydrolase-1 and endo-thelial nitric oxide synthase during myocardial ischemia and reperfusion injury in rats. Anesthesiology. 123:582–589. 2015. View Article : Google Scholar : PubMed/NCBI
12	Guerrero-Orriach JL, Escalona Belmonte JJ, Ramirez Fernandez A, Ramirez Aliaga M, Rubio Navarro M and Cruz Manas J: Cardioprotection with halogenated gases: How does it occur? Drug Des Devel Ther. 11:837–849. 2017. View Article : Google Scholar : PubMed/NCBI
13	Novalija E, Varadarajan SG, Camara AK, An J, Chen Q, Riess ML, Hogg N and Stowe DF: Anesthetic preconditioning: Triggering role of reactive oxygen and nitrogen species in isolated hearts. Am J Physiol Heart Circ Physiol. 283:H44–H52. 2002. View Article : Google Scholar : PubMed/NCBI
14	Amour J, Le Manach YL, Borel M, Lenfant F, Nicolas-Robin A, Carillion A, Ripart J, Riou B and Langeron O: Comparison of single-use and reusable metal laryngoscope blades for orotracheal intubation during rapid sequence induction of anesthesia: A multicenter cluster randomized study. Anesthesiology. 112:325–332. 2010. View Article : Google Scholar : PubMed/NCBI
15	Stowe DF, Gadicherla AK, Zhou Y, Aldakkak M, Cheng Q, Kwok WM, Jiang MT, Heisner JS, Yang M and Camara AK: Protection against cardiac injury by small Ca(2+)-sensitive K(+) channels identified in guinea pig cardiac inner mitochondrial membrane. Biochim Biophys Acta. 1828:427–442. 2013. View Article : Google Scholar
16	Chatterjee A, Black SM and Catravas JD: Endothelial nitric oxide (NO) and its pathophysiologic regulation. Vascul Pharmacol. 49:134–140. 2008. View Article : Google Scholar : PubMed/NCBI
17	Thomas SR, Chen K and Keaney JF Jr: Oxidative stress and endothelial nitric oxide bioactivity. Antioxid Redox Signal. 5:181–194. 2003. View Article : Google Scholar : PubMed/NCBI
18	Vasquez-Vivar J, Kalyanaraman B, Martasek P, Hogg N, Masters BS, Karoui H, Tordo P and Pritchard KA Jr: Superoxide generation by endothelial nitric oxide synthase: The influence of cofactors. Proc Natl Acad Sci USA. 95:9220–9225. 1998. View Article : Google Scholar : PubMed/NCBI
19	Hemmens B and Mayer B: Enzymology of nitric oxide synthases. Methods Mol Biol. 100:1–32. 1998.
20	Leucker TM, Ge ZD, Procknow J, Liu Y, Shi Y, Bienengraeber M, Warltier DC and Kersten JR: Impairment of endothelial-myocardial interaction increases the susceptibility of cardiomyocytes to ischemia/reperfusion injury. PLoS One. 8:e700882013. View Article : Google Scholar : PubMed/NCBI
21	Vasquez-Vivar J, Kalyanaraman B and Martasek P: The role of tetrahydrobiopterin in superoxide generation from eNOS: Enzymology and physiological implications. Free Radic Res. 37:121–127. 2003. View Article : Google Scholar : PubMed/NCBI
22	Gorren AC, List BM, Schrammel A, Pitters E, Hemmens B, Werner ER, Schmidt K and Mayer B: Tetrahydrobiopterin-free neuronal nitric oxide synthase: Evidence for two identical highly anticooperative pteridine binding sites. Biochemistry. 35:16735–16745. 1996. View Article : Google Scholar : PubMed/NCBI
23	Moens AL and Kass DA: Tetrahydrobiopterin and cardiovascular disease. Arterioscler Thromb Vasc Biol. 26:2439–2444. 2006. View Article : Google Scholar : PubMed/NCBI
24	Tiefenbacher CP, Lee CH, Kapitza J, Dietz V and Niroomand F: Sepiapterin reduces postischemic injury in the rat heart. Pflugers Arch. 447:1–7. 2003. View Article : Google Scholar : PubMed/NCBI
25	Liu Y, Baumgardt SL, Fang J, Shi Y, Qiao S, Bosnjak ZJ, Vasquez-Vivar J, Xia Z, Warltier DC, Kersten JR and Ge ZD: Transgenic overexpression of GTP cyclohydrolase 1 in cardio-myocytes ameliorates post-infarction cardiac remodeling. Sci Rep. 7:30932017. View Article : Google Scholar
26	Couto GK, Paula SM, Gomes-Santos IL, Negrao CE and Rossoni LV: Exercise training induces eNOS coupling and restores relaxation in coronary arteries of heart failure rats. Am J Physiol Heart Circ Physiol. 314:H878–H887. 2018. View Article : Google Scholar : PubMed/NCBI
27	Vladic N, Ge ZD, Leucker T, Brzezinska AK, Du JH, Shi Y, Warltier DC, Pratt PF Jr and Kersten JR: Decreased tetrahy-drobiopterin and disrupted association of Hsp90 with eNOS by hyperglycemia impair myocardial ischemic preconditioning. Am J Physiol Heart Circ Physiol. 301:H2130–H2139. 2011. View Article : Google Scholar : PubMed/NCBI